← Back to directory

Leonhard Müllauer

Researcher Next ID · RN-040268

Researcher · Biochemistry, Genetics and Molecular Biology

Vienna General Hospital

Vienna, Austria

Accepting doctoral researchersFunding unknown
Works count
474
Citation count
10,156
H-index
51
i10-index
165

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Brain Metastases and Treatment
HER2/EGFR in Cancer Research
Cancer Genomics and Diagnostics
Lymphoma Diagnosis and Treatment
Radiopharmaceutical Chemistry and Applications

Publications

  • Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

    Cancer Discovery · 2021 · 10.1158/2159-8290.cd-21-0538

  • SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers

    Molecular Cancer · 2017 · 10.1186/s12943-016-0568-5

  • Review of cancer treatment with immune checkpoint inhibitors

    Wiener klinische Wochenschrift · 2017 · 10.1007/s00508-017-1285-9

  • Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

    The Lancet Haematology · 2017 · 10.1016/s2352-3026(17)30208-9

  • Molecular pathology of lung cancer: current status and perspectives

    Current Opinion in Oncology · 2017 · 10.1097/cco.0000000000000429

  • Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

    Clinical Cancer Research · 2014 · 10.1158/1078-0432.ccr-13-3355

  • B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ

    Blood · 2013 · 10.1182/blood-2012-10-460741

  • Masked polycythemia Vera (mPV): Results of an international study

    American Journal of Hematology · 2013 · 10.1002/ajh.23585

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

    Leukemia · 2013 · https://doi.org/10.1038/leu.2013.163

  • Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

    Blood · 2012 · 10.1182/blood-2011-11-393819

  • A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

    Blood · 2012 · 10.1182/blood-2012-01-403279

  • BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

    Blood · 2012 · 10.1182/blood-2012-06-429597

  • Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)

    Oncotarget · 2012 · 10.18632/oncotarget.733

  • ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study

    Haematologica · 2012 · 10.3324/haematol.2012.065664

  • Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

    Blood · 2011 · 10.1182/blood-2010-07-293761

  • Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

    Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.34.5298

  • Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis

    Modern Pathology · 2010 · 10.1038/modpathol.2010.224

  • Mucosa-Associated Lymphoid Tissue Lymphoma: Novel Translocations Including Rearrangements of ODZ2, JMJD2C, and CNN3

    Clinical Cancer Research · 2008 · 10.1158/1078-0432.ccr-08-0702

  • Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells

    Cancer Research · 2008 · 10.1158/0008-5472.can-07-2531

  • Diagnostic and Subdiagnostic Accumulation of Mast Cells in the Bone Marrow of Patients with Anaphylaxis: Monoclonal Mast Cell Activation Syndrome

    International Archives of Allergy and Immunology · 2006 · 10.1159/000096442

  • Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites

    Leukemia · 2004 · https://doi.org/10.1038/sj.leu.2403501

  • A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis

    Annals of Hematology · 2002 · 10.1007/s00277-001-0412-9

  • Mutations in apoptosis genes: a pathogenetic factor for human disease

    Mutation Research/Reviews in Mutation Research · 2001 · 10.1016/s1383-5742(01)00057-6

  • Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression

    Hepatology · 1997 · 10.1002/hep.510250420

  • Gelsolin: a candidate for suppressor of human bladder cancer.

    PubMed · 1995

Current projects

    No projects listed.